RICHMOND, BRITISH COLUMBIA--(Marketwire - July 29, 2008) - BioCurex Inc. (OTCBB: BOCX) today announced that it has filed a new patent application to protect certain methods of purifying and detecting RECAF in bodily fluids. The patent application also includes what the company believes - based on available information - to be new methods for tumor imaging and therapy based on RECAF.
